192 related articles for article (PubMed ID: 34508582)
21. Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
Amza A; Yu SN; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Gaynor BD; Keenan JD; Porco TC; Lietman TM
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3128. PubMed ID: 25210836
[TBL] [Abstract][Full Text] [Related]
22. Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
Keenan JD; Gebresillasie S; Stoller NE; Haile BA; Tadesse Z; Cotter SY; Ray KJ; Aiemjoy K; Porco TC; Callahan EK; Emerson PM; Lietman TM
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007442. PubMed ID: 31166952
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions.
Porco TC; Oldenburg CE; Arzika AM; Kalua K; Mrango Z; Cook C; Lebas E; Bailey RL; West SK; Oron AP; Keenan JD; Lietman TM; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1291-1294. PubMed ID: 30734695
[TBL] [Abstract][Full Text] [Related]
24. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B
N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301
[TBL] [Abstract][Full Text] [Related]
25. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
26. Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial.
Sié A; Bountogo M; Zakane A; Compaoré G; Ouedraogo T; Lebas E; Nyatigo F; Hu H; Brogdon J; Arnold BF; Lietman TM; Oldenburg CE
Am J Trop Med Hyg; 2022 Dec; 107(6):1331-1336. PubMed ID: 36343592
[TBL] [Abstract][Full Text] [Related]
27. Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger.
Platts-Mills JA; Ayoub EG; Zhang J; McQuade ETR; Arzika AM; Maliki R; Abdou A; Keenan JD; Lietman TM; Liu J; Houpt ER
Clin Infect Dis; 2022 Aug; 75(3):515-518. PubMed ID: 35020888
[TBL] [Abstract][Full Text] [Related]
28. A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.
Sié A; Ouattara M; Bountogo M; Bagagnan C; Coulibaly B; Boudo V; Lebas E; Brogdon JM; Lin Y; Bärnighausen T; Porco TC; Doan T; Lietman TM; Oldenburg CE;
Trials; 2019 Dec; 20(1):675. PubMed ID: 31801563
[TBL] [Abstract][Full Text] [Related]
29. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
[TBL] [Abstract][Full Text] [Related]
30. Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger.
Arzika AM; Maliki R; Boubacar N; Kane S; Cook CA; Lebas E; Lin Y; O'Brien KS; Austin A; Keenan JD; Lietman TM; Oldenburg CE; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1315-1318. PubMed ID: 32067628
[TBL] [Abstract][Full Text] [Related]
31. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
[TBL] [Abstract][Full Text] [Related]
32. Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial.
Peterson B; Arzika AM; Amza A; Maliki R; Mankara Karamba A; Moussa M; Kemago M; Liu Z; Houpt E; Liu J; Pholwat S; Doan T; Porco T; Keenan JD; Lietman TM; O'Brien KS
Clin Infect Dis; 2024 May; ():. PubMed ID: 38739754
[TBL] [Abstract][Full Text] [Related]
33. Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7-11 Years.
Brennhofer SA; Rogawski McQuade ET; Zhang J; Pholwat S; Stroup S; Platts-Mills JA; Liu J; Houpt ER
Am J Trop Med Hyg; 2023 Feb; 108(2):428-432. PubMed ID: 36535258
[TBL] [Abstract][Full Text] [Related]
34. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
[TBL] [Abstract][Full Text] [Related]
35. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
[TBL] [Abstract][Full Text] [Related]
36. Morbidity in a Longitudinal Cohort of Children Residing in Villages Randomized to Biannual Treatment With Azithromycin Versus Placebo.
West SK; Bloch E; Weaver J; Munoz B; Mrango Z; Kasubi M; Lietman T; Coles C
Clin Infect Dis; 2020 Feb; 70(4):574-580. PubMed ID: 30950493
[TBL] [Abstract][Full Text] [Related]
37. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.
Adubra L; Alber D; Ashorn P; Ashorn U; Cheung YB; Cloutman-Green E; Diallo F; Ducker C; Elovainio R; Fan YM; Gates L; Gruffudd G; Haapaniemi T; Haidara F; Hallamaa L; Ihamuotila R; Klein N; Luoma J; Martell O; Sow S; Vehmasto T;
Trials; 2023 Jan; 24(1):5. PubMed ID: 36597115
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
[TBL] [Abstract][Full Text] [Related]
39. Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial.
Pavlinac PB; Singa BO; Tickell KD; Brander RL; McGrath CJ; Amondi M; Otieno J; Akinyi E; Rwigi D; Carreon JD; Tornberg-Belanger SN; Nduati R; Babigumira JB; Meshak L; Bogonko G; Kariuki S; Richardson BA; John-Stewart GC; Walson JL
Lancet Glob Health; 2021 Nov; 9(11):e1569-e1578. PubMed ID: 34559992
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
